Methoxy polyethylene glycol-epoetin beta Completed Phase 4 Trials for Anemia Associated With End Stage Renal Disease (ESRD) Treatment

Indications	Status	Purpose	Phase
DBCOND0129746 (Anemia Associated With End Stage Renal Disease (ESRD))	Completed	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT02049346	Comparison Among Erythropoietin Stimulating Agents	Benzalkonium (DB11105) Darbepoetin alfa (DB00012) Erythropoietin (DB00016) Methoxy polyethylene glycol-epoetin beta (DB09107)